Pharmacology of the potassium channel openers Gillian EdwardsArthur H. Weston OriginalPaper Pages: 185 - 193
Electrophysiologic effects of potassium channel openers Wilhelm HaverkampMartin BorggrefeGünter Breithardt OriginalPaper Pages: 195 - 202
Effects of nicorandil on regional perfusion and left ventricular function M. SchlepperJ. ThormannV. Mitrovic OriginalPaper Pages: 203 - 211
Double-blind comparison of the acute effects of two relevant doses of oral nicorandil on central hemodynamics, left ventricular function, and myocardial contractility Andreas BaumbachUte BraunKarl R. Karsch OriginalPaper Pages: 213 - 220
Potassium channel openers: Clinical applications in ischemic heart disease—Overview of clinical efficacy of nicorandil Charles KnightHenry PurcellKim Fox OriginalPaper Pages: 229 - 236
Nicorandil safety in the long-term treatment of coronary heart disease Serge WitchitzJean-Yves Darmon OriginalPaper Pages: 237 - 243
Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels Icilio CaveroYasmine DjellasJean-Michel Guillon OriginalPaper Pages: 245 - 255
Antiischemic effects of nicorandil during coronary angioplasty in humans Satoshi SaitoTsuneo MizumuraKazushige Sakai OriginalPaper Pages: 257 - 263